scholarly article | Q13442814 |
P50 | author | Daria L Manalo | Q89850271 |
Jonathan D Kurtis | Q124651007 | ||
Remigio M Olveda | Q124651008 | ||
Gretchen C. Langdon | Q127461305 | ||
Luz P. Acosta | Q127470500 | ||
Jennifer Friedman | Q42650087 | ||
P2093 | author name string | Hai-Wei Wu | |
Tjalling Leenstra | |||
Sunthorn Pond-Tor | |||
Blanca Jarilla | |||
Mario Jiz | |||
Archie Pablo | |||
P2860 | cites work | Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica | Q24646962 |
A semi-automated multiplex high-throughput assay for measuring IgG antibodies against Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasma | Q28384693 | ||
Evidence for IgE-dependent cytotoxicity by rat eosinophils | Q70731646 | ||
Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma | Q79249028 | ||
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis | Q29619819 | ||
Paramyosin is a major target of the human IgA response against Schistosoma japonicum | Q30822008 | ||
Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: similarity of IgE-binding epitopes to allergen peptides. | Q31994586 | ||
Regulation of the immune response in experimental and human schistosomiasis: the limits of an attractive paradigm | Q33798142 | ||
Is there immunity to Schistosoma japonicum? | Q33868240 | ||
Human immune responses to Schistosoma mansoni vaccine candidate antigens | Q34004360 | ||
T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum | Q34301170 | ||
Blueprint for schistosomiasis vaccine development | Q34646730 | ||
Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China. | Q34646760 | ||
Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? | Q36056272 | ||
Schistosomes: the road from host-parasite interactions to vaccines in clinical trials | Q36056288 | ||
Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies | Q36353120 | ||
Interrelationship among asthma, atopy, and helminth infections | Q36956282 | ||
Antigen-specific antibody isotype patterns to schistosoma japonicum recombinant and native antigens in a defined population in Leyte, the Philippines | Q38859401 | ||
In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens | Q38866692 | ||
Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens | Q38879002 | ||
Human susceptibility to Schistosoma japonicum in China correlates with antibody isotypes to native antigens | Q39177819 | ||
Expression, purification, and human antibody response to a 67 kDa vaccine candidate for schistosomiasis japonica | Q39477245 | ||
Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment | Q39826161 | ||
Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium | Q41162010 | ||
Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity | Q41255530 | ||
The global epidemiological situation of schistosomiasis and new approaches to control and research | Q42007538 | ||
Blocking activity of rat monoclonal antibodies in experimental schistosomiasis | Q43523836 | ||
The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil | Q44071866 | ||
Eosinophils as mediators of antibody-dependent damage to schistosomula | Q44775479 | ||
Human IgE response to the Schistosoma haematobium 22.6 kDa antigen. | Q45243644 | ||
IgA antibodies to a protective antigen in human Schistosomiasis mansoni | Q46627702 | ||
Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. | Q51827445 | ||
Human schistosomiasis: potential long-term consequences of vaccination programmes. | Q52255329 | ||
Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum. | Q54147190 | ||
Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. | Q54230753 | ||
Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. | Q54268997 | ||
Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. | Q54457069 | ||
The isolation of a 22 kDa band after SDS-PAGE of Schistosoma mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to reinfection | Q58312879 | ||
Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni | Q58312953 | ||
Antibody-dependent cell-mediated damage to schistosomula in vitro | Q59066650 | ||
The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes | Q67279316 | ||
Rat mast cell-eosinophil interaction in antibody-dependent eosinophil cytotoxicity to Schistosoma mansoni schistosomula | Q67418065 | ||
Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways | Q67691873 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunoglobulin G | Q79448 |
immunoglobulin E | Q79455 | ||
tropomyosin | Q418454 | ||
Schistosoma japonicum | Q1256989 | ||
local disease | Q11086612 | ||
helminth antigen | Q64734112 | ||
P304 | page(s) | 2051-2058 | |
P577 | publication date | 2009-03-09 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4. | |
P478 | volume | 77 |
Q24599525 | Allergenicity of carbohydrates and their role in anaphylactic events |
Q39448421 | Allergic Sensitization Underlies Hyperreactive Antigen-Specific CD4+ T Cell Responses in Coincident Filarial Infection |
Q28475501 | Analysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: the influence of age, sex, ethnicity and IgE |
Q56909277 | Antibody Responses to Schistosoma mansoni Schistosomula Antigens |
Q35088439 | Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil |
Q34400053 | Bilharzia: Pathology, Diagnosis, Management and Control |
Q38655300 | Characterization of Sarcoptes scabiei Tropomyosin and Paramyosin: Immunoreactive Allergens in Scabies |
Q89599924 | Comparison of immune responses to Loa loa stage-specific antigen extracts in Loa loa-exposed BALB/c mice upon clearance of infection |
Q52742149 | Cross-reactive antigens for natural IgE antibodies: allergens with the potential to transform a dormant to an active allergic response? |
Q28538911 | Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity |
Q26800164 | Development of Paramyosin as a Vaccine Candidate for Schistosomiasis |
Q37680704 | Development of a specimen-sparing multichannel bead assay to detect antiparasite IgG4 for the diagnosis of Schistosoma and Wuchereria infections on the coast of Kenya |
Q34500892 | Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray |
Q92238880 | Effects of the Environment on Developmental Plasticity and Infection Success of Schistosoma Parasites - An Epigenetic Perspective |
Q36506153 | Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections |
Q34496255 | Efficacy and safety of arachidonic acid for treatment of Schistosoma mansoni-infected children in Menoufiya, Egypt |
Q38193093 | Helminth Allergens, Parasite-Specific IgE, and Its Protective Role in Human Immunity |
Q28542932 | Host determinants of reinfection with schistosomes in humans: a systematic review and meta-analysis |
Q33634824 | Human IgE responses to different splice variants of Schistosoma mansoni tropomyosin: associations with immunity |
Q36210573 | Human schistosome infection and allergic sensitisation |
Q41373939 | Immuno-evasive tactics by schistosomes identify an effective allergy preventative |
Q34782228 | Immunology of human schistosomiasis |
Q33611746 | Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases |
Q36283976 | Innate immunostimulatory properties of allergens and their relevance to food allergy |
Q37994231 | Parasite glycans and antibody-mediated immune responses in Schistosoma infection |
Q35487637 | Pilot Study on Interferon-γ-producing T Cell Subsets after the Protective Vaccination with Radiation-attenuated Cercaria of Schistosoma japonicum in the Miniature Pig Model |
Q35626870 | Proteomic analysis of the excretory/secretory products and antigenic proteins of Echinococcus granulosus adult worms from infected dogs |
Q34654313 | Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils |
Q33723867 | Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective |
Q34626126 | Repeated Schistosoma japonicum infection following treatment in two cohorts: evidence for host susceptibility to helminthiasis? |
Q36158825 | Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies |
Q33825627 | Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam. |
Q90240652 | Schistosomiasis in the Philippines: Innovative Control Approach is Needed if Elimination is the Goal |
Q28066042 | Schistosomiasis vaccines: where do we stand? |
Q57152572 | The Interdependence between Schistosome Transmission and Protective Immunity |
Q45904864 | Tissue expression and the host's immunological recognition of a Rhipicephalus microplus paramyosin. |
Q34256750 | Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins |
Q39604709 | Vaccination with recombinant paramyosin in Montanide ISA206 protects against Schistosoma japonicum infection in water buffalo |
Search more.